Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression

Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 2017-07, Vol.106 (7), p.1772-1777
Hauptverfasser: Sun, Wei-Jhe, Aburub, Aktham, Sun, Changquan Calvin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1777
container_issue 7
container_start_page 1772
container_title Journal of pharmaceutical sciences
container_volume 106
creator Sun, Wei-Jhe
Aburub, Aktham
Sun, Changquan Calvin
description Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes.
doi_str_mv 10.1016/j.xphs.2017.03.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1879666344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354917301612</els_id><sourcerecordid>1879666344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-982fae671d3dfa4737e560020f3e198252577e1ecb8b531cb2059ddc0cdc81f43</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhq0KVBboH-ih8pFL0rEd50PqpVo-WmkRK7E9W44zoV4l8dZOoPDr6-xSjpxGM_PMK81DyGcGKQOWf92mf3e_Q8qBFSmIFEB-IAsmOSR5HB2RBQDniZBZdUJOQ9gCQA5SfiQnvBScVxksyMta-9GaDunV8GAHRG-HB9o6H3tdd3Oj6bXz_dTp0bqBrmON657eT3aMBO7hWz1MrTbjtD9fuafk0gWkmxkYA62f6aX1aEa6dP3OYwgx6pwct7oL-Om1npFf11eb5Y9kdXfzc_l9lZiM8zGpSt5qzAvWiKbVWSEKlHn8DFqBLC4ll0WBDE1d1lIwU3OQVdMYMI0pWZuJM3JxyN1592fCMKreBoNdpwd0U1CsLKo8z0U2o_yAGu9C8Niqnbe99s-KgZqdq62anavZuQKhovN49OU1f6p7bN5O_kuOwLcDgPHLR4teBWNxMNjsnajG2ffy_wEX6ZRf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1879666344</pqid></control><display><type>article</type><title>Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Sun, Wei-Jhe ; Aburub, Aktham ; Sun, Changquan Calvin</creator><creatorcontrib>Sun, Wei-Jhe ; Aburub, Aktham ; Sun, Changquan Calvin</creatorcontrib><description>Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1016/j.xphs.2017.03.005</identifier><identifier>PMID: 28322940</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>content uniformity ; Drug Carriers - chemistry ; Drug Compounding - methods ; Excipients - chemistry ; formulation ; manufacturability ; Neusilin ; particle engineering ; Pharmaceutical Preparations - administration &amp; dosage ; Pharmaceutical Preparations - chemistry ; Porosity ; Powders ; Solubility ; tableting ; Tablets - chemistry</subject><ispartof>Journal of pharmaceutical sciences, 2017-07, Vol.106 (7), p.1772-1777</ispartof><rights>2017 American Pharmacists Association</rights><rights>Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-982fae671d3dfa4737e560020f3e198252577e1ecb8b531cb2059ddc0cdc81f43</citedby><cites>FETCH-LOGICAL-c422t-982fae671d3dfa4737e560020f3e198252577e1ecb8b531cb2059ddc0cdc81f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28322940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Wei-Jhe</creatorcontrib><creatorcontrib>Aburub, Aktham</creatorcontrib><creatorcontrib>Sun, Changquan Calvin</creatorcontrib><title>Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression</title><title>Journal of pharmaceutical sciences</title><addtitle>J Pharm Sci</addtitle><description>Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes.</description><subject>content uniformity</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Compounding - methods</subject><subject>Excipients - chemistry</subject><subject>formulation</subject><subject>manufacturability</subject><subject>Neusilin</subject><subject>particle engineering</subject><subject>Pharmaceutical Preparations - administration &amp; dosage</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Porosity</subject><subject>Powders</subject><subject>Solubility</subject><subject>tableting</subject><subject>Tablets - chemistry</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P3DAQhq0KVBboH-ih8pFL0rEd50PqpVo-WmkRK7E9W44zoV4l8dZOoPDr6-xSjpxGM_PMK81DyGcGKQOWf92mf3e_Q8qBFSmIFEB-IAsmOSR5HB2RBQDniZBZdUJOQ9gCQA5SfiQnvBScVxksyMta-9GaDunV8GAHRG-HB9o6H3tdd3Oj6bXz_dTp0bqBrmON657eT3aMBO7hWz1MrTbjtD9fuafk0gWkmxkYA62f6aX1aEa6dP3OYwgx6pwct7oL-Om1npFf11eb5Y9kdXfzc_l9lZiM8zGpSt5qzAvWiKbVWSEKlHn8DFqBLC4ll0WBDE1d1lIwU3OQVdMYMI0pWZuJM3JxyN1592fCMKreBoNdpwd0U1CsLKo8z0U2o_yAGu9C8Niqnbe99s-KgZqdq62anavZuQKhovN49OU1f6p7bN5O_kuOwLcDgPHLR4teBWNxMNjsnajG2ffy_wEX6ZRf</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Sun, Wei-Jhe</creator><creator>Aburub, Aktham</creator><creator>Sun, Changquan Calvin</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression</title><author>Sun, Wei-Jhe ; Aburub, Aktham ; Sun, Changquan Calvin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-982fae671d3dfa4737e560020f3e198252577e1ecb8b531cb2059ddc0cdc81f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>content uniformity</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Compounding - methods</topic><topic>Excipients - chemistry</topic><topic>formulation</topic><topic>manufacturability</topic><topic>Neusilin</topic><topic>particle engineering</topic><topic>Pharmaceutical Preparations - administration &amp; dosage</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Porosity</topic><topic>Powders</topic><topic>Solubility</topic><topic>tableting</topic><topic>Tablets - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Wei-Jhe</creatorcontrib><creatorcontrib>Aburub, Aktham</creatorcontrib><creatorcontrib>Sun, Changquan Calvin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Wei-Jhe</au><au>Aburub, Aktham</au><au>Sun, Changquan Calvin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J Pharm Sci</addtitle><date>2017-07</date><risdate>2017</risdate><volume>106</volume><issue>7</issue><spage>1772</spage><epage>1777</epage><pages>1772-1777</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><abstract>Maintaining good content uniformity (CU) is a significant challenge for low-dose oral tablets in particular when using direct compression (DC). Using 6 model active pharmaceutical ingredients, we show that a platform DC tablet formulation suitable for developing low-dose API with excellent CU can be developed. This platform formulation is enabled by particle engineering, where an API of interest is loaded in a suitable porous carrier to form a uniform API-carrier composite. Powder properties of such composite particles are dictated by the properties of the carrier, which are insensitive to chemical structure and loading level of the API. Powder flowability, tabletability, tablet friability, and tablet disintegration time are all excellent and only vary within a narrow range among the 6 model APIs. Nearly 100% drug can be released in water from tablets composed of the 6 model APIs. Thus, the approach described here holds the promise for broad application in developing low-dose tablet products using DC possessing excellent CU and other critical quality attributes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28322940</pmid><doi>10.1016/j.xphs.2017.03.005</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 2017-07, Vol.106 (7), p.1772-1777
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_1879666344
source MEDLINE; Alma/SFX Local Collection
subjects content uniformity
Drug Carriers - chemistry
Drug Compounding - methods
Excipients - chemistry
formulation
manufacturability
Neusilin
particle engineering
Pharmaceutical Preparations - administration & dosage
Pharmaceutical Preparations - chemistry
Porosity
Powders
Solubility
tableting
Tablets - chemistry
title Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T07%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Particle%20Engineering%20for%20Enabling%20a%20Formulation%20Platform%20Suitable%20for%20Manufacturing%20Low-Dose%20Tablets%20by%20Direct%20Compression&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Sun,%20Wei-Jhe&rft.date=2017-07&rft.volume=106&rft.issue=7&rft.spage=1772&rft.epage=1777&rft.pages=1772-1777&rft.issn=0022-3549&rft.eissn=1520-6017&rft_id=info:doi/10.1016/j.xphs.2017.03.005&rft_dat=%3Cproquest_cross%3E1879666344%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1879666344&rft_id=info:pmid/28322940&rft_els_id=S0022354917301612&rfr_iscdi=true